Monthly reportEDA
Egyptian Drug Authority — April 2026
What this register recorded from EDA in April 2026, what other African authorities published in the same month that bears on it, and what we could not read in EDA’s own notices. Every figure here is a count of published regulatory actions. None of it is a finding about Egyptian Drug Authority.
What EDA published
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-EG-2026-0024 | Apr 2026 | EG | Cialis 20 MG | D753224 | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0025 | Apr 2026 | EG | Omnipaque 300 mg/ml GE healthcare Ireland | 17350896 · 17334249 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-EG-2026-0026 | Apr 2026 | EG | FLOPADEX 8mg Hard Gelatin Capsules | 2411226 | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0027 | Apr 2026 | EG | JUSTIN Blue Hair Anti-Dandruff Shampoo | 022 | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0028 | Apr 2026 | EG | Tavanic 500mg | FEG026 | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0029 | Apr 2026 | EG | Rhophylac300 | p100341268 · P100351346 | Recall | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0030 | Apr 2026 | EG | Touchstone | none published | Recall | Class II | Tier 1 · Regulator-published |
| DEA-EG-2026-0031 | Apr 2026 | EG | Staturic 40 mg P&C Labs for bio Med for pharmaceutical industries (BIOMED) | 251116 · 251117 · 251118 · 251119 · 251120 · 251121 · 251122 · 251123 · 251124 · 251125 · 251126 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-EG-2026-0032 | Apr 2026 | EG | Enolotax 250 mg HGC شركة الحكمة | 242196 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-EG-2026-0033 | Apr 2026 | EG | Infusion pump set with Regulator كيو للصناعات البلاستيكية | 0325 · 0925 | Recall | Class III | Tier 1 · Regulator-published |
| DEA-EG-2026-0034 | Apr 2026 | EG | Dexamethasone -INAD PHARMA Solution for injection/infusion 8 mg\2ml | 1587 · 1476 · 1571 · 1449 · 1451 · 1587-1589 · 1589 | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0035 | Apr 2026 | EG | Keytruda injection 100 mg \4 ml | S20491 | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0036 | Apr 2026 | EG | OTIX LIV DROP LOTION ANTIFUNGAL 15ML OTIX LIV SPRAY LOTION ANTIFUNGAL 60ML | 090925 · 080925 | Public warning | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2026-0037 | Apr 2026 | EG | FASTRINE Spray for Oral Cavity Care 60 ML (PEPPERMINT FLAVOR) | 0324 | Public warning | Unclassified | Tier 1 · Regulator-published |
What other authorities published
EDA and the WHO alert
- Substandard iohexol contrast media — (DEA-EG-2026-0025)
What we could not read in EDA’s notices
- 336 record(s) held from EDA in total
- 5 carry no publication date we could read
- 43 name neither a batch nor a stated reason
- 247 name no manufacturer
- 5 are searchable and API-available but carry noindex, because they are too incomplete for a public URL
- 0 have no archived copy of the original notice
Correcting this
Anything on this page that is wrong about Egyptian Drug Authority can be corrected by Egyptian Drug Authority, and a record published by one of its officers carries verification tier 0 — the rank only the issuing regulator can create. Nothing else on this register does.